Chlamydia trachomatis serology:: Protein 2 compared with that of other antigens diagnostic value of outer membrane

被引:35
作者
Bas, S [1 ]
Muzzin, P
Vischer, TL
机构
[1] Univ Hosp Geneva, Dept Internal Med, Div Rheumatol, CH-1211 Geneva 14, Switzerland
[2] Sch Med, Dept Med Biochem, CH-1211 Geneva, Switzerland
关键词
D O I
10.1128/JCM.39.11.4082-4085.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Different immunoassays using recombinant antigens or synthetic peptides were evaluated for the serodiagnosis of Chlamydia trachomatis infections. Antigens used included cysteine-rich outer membrane protein 2 (OMP2), heat shock protein 60, the polypeptide encoded by open reading frame 3 of the plasmid (pgp3), synthetic peptides derived from species-specific epitopes in variable domain IV of the major OMP (MOMP) (Labsystems, Helsinki, Finland), and a fragment of the total lipopolysaccharide (Medac, Hamburg, Germany). Because cross-reactions between chlamydial species have been reported, Chlamydia pneumoniae-specific antibodies were also determined by immunoassays (Labsystems). Responses obtained with serum samples from patients with well-defined diseases (i.e., urethral or endocervical samples from which C. trachomatis DNA was amplified) were compared to those obtained with samples from healthy blood donors. The best sensitivity (79%) associated with the best specificity (82%) was obtained when immunoglobulin G (IgG) responses to both MOMP and pgp3 were considered. The highest sensitivity (89%) was obtained with anti-OMP2 IgG, but the lowest specificity (57%) was obtained with this antibody, due to probable cross-reactivity with C. pneumoniae OMP2.
引用
收藏
页码:4082 / 4085
页数:4
相关论文
共 11 条
[1]   IDENTIFICATION BY SEQUENCE-ANALYSIS OF 2-SITE POSTTRANSLATIONAL PROCESSING OF THE CYSTEINE-RICH OUTER-MEMBRANE PROTEIN-2 OF CHLAMYDIA-TRACHOMATIS SEROVAR-L2 [J].
ALLEN, JE ;
STEPHENS, RS .
JOURNAL OF BACTERIOLOGY, 1989, 171 (01) :285-291
[2]  
Bas S, 1998, BRIT J RHEUMATOL, V37, P1054
[3]   Chlamydial serology: Comparative diagnostic value of immunoblotting, microimmunofluorescence test, and immunoassays using different recombinant proteins as antigens [J].
Bas, S ;
Muzzin, P ;
Ninet, B ;
Bornand, JE ;
Scieux, C ;
Vischer, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1368-1377
[4]  
Bas S, 1996, BRIT J RHEUMATOL, V35, P542
[5]   IDENTIFICATION OF CHLAMYDIA PNEUMONIAE-SPECIFIC PROTEIN ANTIGENS IN IMMUNOBLOTS [J].
FREIDANK, HM ;
HERR, AS ;
JACOBS, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (12) :947-951
[6]   CHLAMYDIA-PNEUMONIAE IGG ANTIBODY PREVALENCE IN SOUTH-WESTERN AND EASTERN FINLAND IN 1982 AND 1987 [J].
KARVONEN, M ;
TUOMILEHTO, J ;
PITKANIEMI, J ;
NAUKKARINEN, A ;
SAIKKU, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (01) :176-184
[7]   ISOLATION AND SEQUENCE-ANALYSIS OF THE CHLAMYDIA-PNEUMONIAE GROE OPERON [J].
KIKUTA, LC ;
PUOLAKKAINEN, M ;
KUO, CC ;
CAMPBELL, LA .
INFECTION AND IMMUNITY, 1991, 59 (12) :4665-4669
[8]   CHLAMYDIA-PNEUMONIAE (TWAR) [J].
KUO, CC ;
JACKSON, LA ;
CAMPBELL, LA ;
GRAYSTON, JT .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :451-&
[9]   Analysis of the humoral immune response to Chlamydia outer membrane protein 2 [J].
Mygind, P ;
Christiansen, G ;
Persson, K ;
Birkelund, S .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (03) :313-318
[10]   DIFFERENTIAL HUMAN SEROLOGIC RESPONSE TO 2 60,000 MOLECULAR-WEIGHT CHLAMYDIA-TRACHOMATIS ANTIGENS [J].
WAGAR, EA ;
SCHACHTER, J ;
BAVOIL, P ;
STEPHENS, RS .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :922-927